GLP1R and type 2 diabetes mellitus: With the recent FDA-approval of the daily injectable glucagon-like peptide-1 receptor agonist (GLP-1 RA) liraglutide, there is now another safe and effective option for treatment of T2DM in youth that promotes both weight loss and improves glycemic control.